Telangana – 29th state of India
Telangana becomes a reality as the 29th state of India, capping the decades-old struggle in the region for carving out a separate state from Andhra Pradesh. President’s rule imposed in … continue reading
IAS
14 year old Poorna becomes youngest to climb Mount Everest
A 14-year old girl from Andhra Pradesh has become the youngest woman to climb Mount Everest, the highest peak in the world. Poorna is from the Nizamabad district of Andhra … continue reading
HIV :: HIV-TB spreads in Africa, undermines control of world’s 2 deadliest infectious diseases
The largely unnoticed collision of the global epidemics of HIV and tuberculosis (TB) has exploded to create a deadly co-epidemic that is rapidly spreading in sub-Saharan Africa. However, health systems cannot adequately diagnose, treat, or contain the co-epidemic due to unanswered scientific and medical questions, according to a report issued today by The Forum for Collaborative HIV Research and amplified by experts from leading global health organizations.
HIV :: AHF Welcomes FDA Approval of Pfizer?s Selzentry AIDS Drug
On the heels of the fourth International AIDS Society?s Conference on HIV Pathogenesis, Treatment and Prevention, which took place in Sydney in late July, AIDS Healthcare Foundation (AHF) welcomed yesterday?s news that the FDA has approved Pfizer Inc.?s new AIDS salvage therapy, Selzentry (maraviroc), a different class of new antiretroviral AIDS drug which had been discussed and presented at the IAS conference.
HIV :: Tibotec submits marketing authorisation application for investigational HIV treatment TMC125 in Europe
Tibotec Pharmaceuticals Ltd. announced that it has submitted an application for marketing authorisation for TMC125 to the European Agency for the Evaluation of Medicinal Products (EMEA).
HIV :: Sex, drugs and HIV
The rise in the number of Australian HIV cases in the past seven years is likely to be related to risky sexual behaviour in men having sex with men, according to work co-authored by UNSW researchers.
HIV :: Abbott agrees to drop lawsuit against Act Up-Paris
The International AIDS Society (IAS) convened and facilitated a meeting between Act Up-Paris and Abbott in Sydney, Australia.
HIV :: New publication presents latest in HIV/TB treatment, research
With HIV infection driving a deadly resurgence of tuberculosis (TB), a new publication provides up-to-date recommendations for clinicians facing the many challenges of treating patients with both of these two complex diseases.
HIV :: TMC125 demonstrates efficacy in patients with NNRTI resistance in phase III trials
TMC125 (etravirine, ETR), Tibotec’s investigational next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), demonstrated significant efficacy in patients with NNRTI resistance, according to the 24-week primary endpoint analysis from two ongoing, phase III studies published in the 7 July, 2007, issue of The Lancet.
HIV :: Darunavir with FUZEON provides HIV patients a better chance to reach undetectable viral load
Imminent arrival of latest HIV drug darunavir, when combined with FUZEON, will give treatment-experienced patients a better chance to achieve undetectable viral load.